These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8389106)

  • 1. Acute bronchodilation with an intravenously administered leukotriene D4 antagonist, MK-679.
    Impens N; Reiss TF; Teahan JA; Desmet M; Rossing TH; Shingo S; Zhang J; Schandevyl W; Verbesselt R; Dupont AG
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1442-6. PubMed ID: 8389106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma.
    Gaddy JN; Margolskee DJ; Bush RK; Williams VC; Busse WW
    Am Rev Respir Dis; 1992 Aug; 146(2):358-63. PubMed ID: 1489125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
    Manning PJ; Watson RM; Margolskee DJ; Williams VC; Schwartz JI; O'Byrne PM
    N Engl J Med; 1990 Dec; 323(25):1736-9. PubMed ID: 2174121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics.
    Dahlén B; Kumlin M; Margolskee DJ; Larsson C; Blomqvist H; Williams VC; Zetterström O; Dahlén SE
    Eur Respir J; 1993 Jul; 6(7):1018-26. PubMed ID: 8396534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.
    Reiss TF; Altman LC; Chervinsky P; Bewtra A; Stricker WE; Noonan GP; Kundu S; Zhang J
    J Allergy Clin Immunol; 1996 Sep; 98(3):528-34. PubMed ID: 8828530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.
    Kips JC; Joos GF; De Lepeleire I; Margolskee DJ; Buntinx A; Pauwels RA; Van der Straeten ME
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):617-21. PubMed ID: 1892302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
    De Lepeleire I; Reiss TF; Rochette F; Botto A; Zhang J; Kundu S; Decramer M
    Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids.
    Reiss TF; Sorkness CA; Stricker W; Botto A; Busse WW; Kundu S; Zhang J
    Thorax; 1997 Jan; 52(1):45-8. PubMed ID: 9039239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects.
    Dahlén B; Margolskee DJ; Zetterström O; Dahlén SE
    Thorax; 1993 Dec; 48(12):1205-10. PubMed ID: 8303624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma.
    Rasmussen JB; Eriksson LO; Margolskee DJ; Tagari P; Williams VC; Andersson KE
    J Allergy Clin Immunol; 1992 Aug; 90(2):193-201. PubMed ID: 1323587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of the oral neutral endopeptidase inhibitor candoxatril, on bronchomotor tone and histamine reactivity in asthma.
    Angus RM; McCallum MJ; Nally JE; Thomson NC
    Eur Respir J; 1994 Jun; 7(6):1084-9. PubMed ID: 7925877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchodilator properties of an inhaled leukotriene D4 antagonist (verlukast--MK-0679) in asthmatic patients.
    Lammers JW; Van Daele P; Van den Elshout FM; Decramer M; Buntinx A; De Lepeleire I; Friedman B
    Pulm Pharmacol; 1992 Jun; 5(2):121-5. PubMed ID: 1611229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and tolerability of MK-0633, a 5-lipoxygenase inhibitor, in chronic asthma.
    Wasfi YS; Villarán C; de Tilleghem Cle B; Smugar SS; Hanley WD; Reiss TF; Knorr BA
    Respir Med; 2012 Jan; 106(1):34-46. PubMed ID: 21945511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchodilator, cardiovascular, and cyclic guanylyl monophosphate response to high-dose infused atrial natriuretic peptide in asthma.
    Angus RM; McCallum MJ; Hulks G; Thomson NC
    Am Rev Respir Dis; 1993 May; 147(5):1122-5. PubMed ID: 8387254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene (LT) D4 is involved in antigen-induced asthma: a study with the LTD4 receptor antagonist, MK-571.
    Rasmussen JB; Margolskee DJ; Eriksson LO; Williams VC; Andersson KE
    Ann N Y Acad Sci; 1991; 629():436. PubMed ID: 1952571
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
    Franciosi LG; Diamant Z; Banner KH; Zuiker R; Morelli N; Kamerling IM; de Kam ML; Burggraaf J; Cohen AF; Cazzola M; Calzetta L; Singh D; Spina D; Walker MJ; Page CP
    Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of intravenous montelukast in acute asthma.
    Camargo CA; Smithline HA; Malice MP; Green SA; Reiss TF
    Am J Respir Crit Care Med; 2003 Feb; 167(4):528-33. PubMed ID: 12456380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma drug profiles and tolerability of MK-571 (L-660,711), a leukotriene D4 receptor antagonist, in man.
    Depré M; Margolskee DJ; Hsieh JY; Van Hecken A; Buntinx A; De Lepeleire I; Rogers JD; De Schepper PJ
    Eur J Clin Pharmacol; 1992; 43(4):427-30. PubMed ID: 1451725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.